Because these reports on the CCL5–CCR5 axis in the CRC tumor microenvironment appear to be contradictory, further investigation is awaited to determine whether the CCL5–CCR5 axis plays a role in anti-tumor immunity or tumor-promotion. This evidence concerns the gene CCL5 and colorectal carcinoma.